These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3554632)
1. Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring. Aranda JV; Beharry K; Rex J; Johannes RJ; Charest-Boule L Ther Drug Monit; 1987; 9(1):97-103. PubMed ID: 3554632 [TBL] [Abstract][Full Text] [Related]
2. Analysis of caffeine: comparison of the manual enzyme multiplied immunoassay (EMIT), automated EMIT, and high-performance liquid chromatography procedures. Miceli JN; Aravind MK; Ferrell WJ Ther Drug Monit; 1984; 6(3):344-7. PubMed ID: 6390796 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method. Zysset T; Wahlländer A; Preisig R Ther Drug Monit; 1984; 6(3):348-54. PubMed ID: 6390797 [TBL] [Abstract][Full Text] [Related]
4. Non-extraction HPLC method for the simultaneous measurement of theophylline and caffeine in human serum. Rainbow SJ; Dawson CM; Tickner TR Ann Clin Biochem; 1989 Nov; 26 ( Pt 6)():527-32. PubMed ID: 2619232 [TBL] [Abstract][Full Text] [Related]
5. Caffeine pharmacokinetics in preterm infants older than 2 weeks. Pearlman SA; Duran C; Wood MA; Maisels MJ; Berlin CM Dev Pharmacol Ther; 1989; 12(2):65-9. PubMed ID: 2714159 [TBL] [Abstract][Full Text] [Related]
6. Comparison of homogeneous enzyme immunoassay and high-pressure liquid chromatography for the determination of theophylline concentration in serum. Koup JR; Brodsky B Am Rev Respir Dis; 1978 Jun; 117(6):1135-8. PubMed ID: 352208 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous caffeine application in the treatment of neonatal apnoea. Amato M; Isenschmid M; Hüppi P Eur J Pediatr; 1991 Jun; 150(8):592-4. PubMed ID: 1954966 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the EMIT reagent system for measurement of caffeine with the EMIT Lab 5000 System and a centrifugal analyzer. Ou CN; Frawley VL; Ellis JM Clin Chem; 1984 Jun; 30(6):887-9. PubMed ID: 6373054 [TBL] [Abstract][Full Text] [Related]
9. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373 [TBL] [Abstract][Full Text] [Related]
10. Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays. Miles MV; Howlett CM; Tennison MB; Greenwood RS; Cross RE Ther Drug Monit; 1989; 11(3):337-42. PubMed ID: 2658212 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic aspects of caffeine in premature infants. De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of caffeine in preterm infants: Could saliva be an alternative to serum? Chaabane A; Chioukh FZ; Chadli Z; Ben Fredj N; Ben Ameur K; Ben Hmida H; Boughattas NA; Monastiri K; Aouam K Therapie; 2017 Dec; 72(6):685-689. PubMed ID: 28964570 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring in a pediatric laboratory. Hale TW; Shum S; Habersang R Dev Pharmacol Ther; 1987; 10(2):81-9. PubMed ID: 3608745 [TBL] [Abstract][Full Text] [Related]
14. [The choice between theophylline and caffeine in the treatment of apnea in premature infants]. Bairam A; Boutroy MJ; Badonnel Y; Vert P Arch Fr Pediatr; 1990; 47(6):461-5. PubMed ID: 2206108 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic considerations in the therapy of neonatal apnea. Aranda JV; Grondin D; Sasyniuk BI Pediatr Clin North Am; 1981 Feb; 28(1):113-33. PubMed ID: 7208132 [TBL] [Abstract][Full Text] [Related]
16. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system. Mendu DR; Chou PP; Soldin SJ Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655 [TBL] [Abstract][Full Text] [Related]
17. A rapid HPLC method for monitoring plasma levels of caffeine and theophylline using solid phase extraction columns. Pickard CE; Stewart AD; Hartley R; Lucock MD Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():440-6. PubMed ID: 3532920 [TBL] [Abstract][Full Text] [Related]
18. DBS-LC-MS/MS assay for caffeine: validation and neonatal application. Bruschettini M; Barco S; Romantsik O; Risso F; Gennai I; Chinea B; Ramenghi LA; Tripodi G; Cangemi G Bioanalysis; 2016 Sep; 8(18):1893-902. PubMed ID: 27532249 [TBL] [Abstract][Full Text] [Related]
19. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. VI: A rapid microscale method for determination of caffeine in plasma and saliva. Sood SP; Green VI; Nieva LL Ther Drug Monit; 1989; 11(3):361-4. PubMed ID: 2658214 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a high performance liquid chromatographic and an enzyme immunoassay technique for quantitation of theophylline in serum. Boeckx RL; Frith EM; Simons FE Ther Drug Monit; 1979; 1(1):65-73. PubMed ID: 399811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]